Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964339 · ClinicalTrials.gov registry record
Obesity Hypoventilation Syndrome Prevalence Study
A clinical trial, sponsored by Philips Respironics.
- Terminated
- Registry status
- 44
- Enrollment target
NCT01964339 is a clinical trial that was terminated before completion, run by Philips Respironics. The registered enrollment target is 44 participants.
The verdict
NCT01964339 was terminated before completion, sponsored by Philips Respironics.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.
Interventions
- OTHER BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.
- OTHER BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-10-09 |
| Est. Completion | 2014-05-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01964339
The ClinicalTrials.gov registry entry for NCT01964339 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study. is the first listed.
NCT01964339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01964339 about?
NCT01964339 is a clinical study titled "Obesity Hypoventilation Syndrome Prevalence Study". This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.
What is the current status of trial NCT01964339?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2013-10-09. Estimated completion is 2014-05-21.
What interventions are being tested in trial NCT01964339?
The interventions under investigation include: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study. (OTHER), BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study. (OTHER).
Who is sponsoring clinical trial NCT01964339?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.